Psychiatry

Most of the patients in the study were taking concomitant antidepressants and/or antipsychotics, and mood disorders remained stable during treatment with valbenazine.

Healthcare provider employment opportunies have risen 7.1%—an increase from 2017's reported rate of 5%. Where are the jobs in most demand?

With a recent FDA approval as the first ever therapy for TD, as well as the first ongoing phase 4 clinical trial, valbenazine use is under close watch by clinicians and specialists.

Patients with tardive syndromes treated with transcranial magnetic stimulation had greater improvement in AIMS scores compared to the sham group.

Ezogabine was not marked as an antidepressant but seemed to be an effective treatment in a small study.

Research with more diverse patient populations is needed to confirm this new discovery.

A meta-analysis of more than 7 million patients confirms that just 1 instance of a concussion or mild TBI is associated with a two-fold greater risk of suicide.

Tardive dyskinesia due to lithium treatment is still rare, but the antipsyhotic therapy substitute was linked to at least 1 particular patient case.

The use of mood-altering medications does not increase odds for hepatic encephalopathy or hepatic encephalopathy-related hospital admissions after TIPS placement, according to the results of a new study.

Patients may have been told they would ‘grow out of’ PKU, and consequently go off-diet, with consequences such as cognitive deficit.

A study of deep brain stimulation in patients with tardive dyskinesia and dystonia reports promising results.

Long-term lung inflammation associated with allergen exposure is linked to the development of anxiety later in adulthood, according to a new study.

A retrospective review finds HIV post-exposure prophylaxis is often prescribed outside of guidelines’ recommendations in response to patients' emotional stress.

A supplemental new drug application (sNDA) for vortioxetine (TRINTELLIX), a prescription medication for the treatment of adults with major depressive disorder (MDD), has been accepted by the FDA.

Increased access to proper mental health care is a key weapon in the battle against the deadly opioid epidemic, according to a recent study.

People with depression exhibit an unexpected increase in volume on the left side of the hypothalamus, the brain region responsible for physical wellbeing.

Patients receiving valbenazine for tardive dyskinesia reported high levels of satisfaction, even after up to 2 years of treatment.

Long-term treatment with valbenazine improved tardive dyskinesia symptoms over 48 weeks.

Results connecting breathlessness catastrophizing with reduced quality of life also have implications for populations with asthma or COPD.

Clinicians should encourage natural light exposure to reduce the risk of postpartum depression in women with third trimesters in the fall, study suggests.

Antipsychotic dose reductions can increase mental illness and all-cause hospitalizations, but the effects on tardive dyskinesia were unclear.

Research demonstrates that medication-assisted treatment for opioid addiction works, yet few have adopted it.

Recent studies questioned the benefits of second-generation antipsychotics, prompting researchers to reassess the risks of tardive dyskinesia from the use of first- and second-generation antipsychotics.

Study highlights differences in prescription of mental health medications for people living with HIV/AIDS.

Instances of sexual harassment are associated with high blood pressure and poor sleep for women in midlife, while sexual assault is associated with poor mental health and sleep.